Login / Signup

Quality of Life Impact in Patients with Cutaneous Toxicities Caused by Epidermal Growth Factor Receptor Inhibitors and Immunotherapy.

Maria ManninoPietro SollenaAlessandro Di StefaniErnesto RossiEttore D'ArgentoGiovanni SchinzariGiampaolo TortoraKetty Peris
Published in: Dermatology (Basel, Switzerland) (2024)
Early patients' referral to dermatologists and tailored management could result in better QoL.
Keyphrases
  • epidermal growth factor receptor
  • end stage renal disease
  • tyrosine kinase
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors